hand, the 19-COOH moiety is important for preventing cellular toxicity associated with 11α-OH KA and its related compounds. These results suggest that 11α-OH KA is an attractive target for potential use in the production of cosmetic items.
droxylation of L -tyrosine to 3,4-dihydroxyphenylalanine and its subsequent oxidation to dopaquinone. Dopaquinone is converted to melanin via enzymatic and nonenzymatic reactions [4] . To achieve skin whitening, control of tyrosinase activity and its expression level is important. A number of substances, including linoleic acid [5] , hinokitiol [6] , kojic acid [7] , hydroquinone [8] , catechols [9] , and salicylate [10] , are widely used in cosmetic items where they act as tyrosinase inhibitors.
The regulation of tyrosinase expression levels in melanocytes is a multistep process. First, UV radiation stimulates keratinocytes to synthesize and secrete α-melanocyte-stimulating hormone (α-MSH) [11] . α-MSH then binds to the melanocortin 1 receptor on the melanocyte membrane, which initiates cAMP signaling in the melanocytes. cAMP signaling activates the transcription factor cAMP response element-binding protein (CREB), which induces the melanogenic transcription factor microphthalmia-associated transcription factor (MITF) [12, 13] . In turn, MITF binds to the tyrosinase promoter and upregulates the expression of this gene. We have recently identified carnosol and canosic acid from Callicarpa longissima as candidates for skin whitening reagents that act by targeting MITF expression [14] .
Here, we report that ent -11α-hydroxy-15-oxo-kaur-16-en-19-oic acid (11α-OH KA), an ingredient in the Pteris dispar Kunze leaf extract strongly inhibited melanin synthesis in B16F10 melanoma cells and in a threedimensional (3D) human skin epidermal model. Although 11α-OH KA did not alter the expression level or activity of MITF in cAMP-agonist (forskolin, Fsk)-treated cells, it significantly suppressed tyrosinase expression levels. Structure-activity relationship analyses revealed that the 11α-OH, 15-oxy, and 16-en moieties were essential for melanogenesis inhibitory activity of 11α-OH KA.
Materials and Methods

Chemicals
Authentic 11α-OH KA and related kaurens were obtained from BioBioPha (Shanghai, China). Antibodies were obtained as follows: anti-tyrosinase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), anti-MITF (Thermo Fisher Scientific Inc., Waltham, MA, USA), anti-GAPDH (WAKO, Kyoto, Japan), anti-CREB (Genscript, Piscataway, NJ, USA), and p38, pp38, ERK1/2, pERK1/2, and pCREB (Cell Signaling Technology, Danvers, MA, USA). Antigen-antibody interactions were visualized using Chemi Doc XRS (Bio-Rad, Hercules, CA, USA) with the Chemi-Lumi One Super reagent (Nacalai Co. Ltd., Kyoto, Japan) or using the chromogenic reagent immunostain horseradish peroxidase (ATTO Co., Ltd., Tokyo, Japan).
Purification and Analysis of 11α-OH KA
Fifty grams of dried powder made from the leaves of P. dispar Kunze was soaked in 500 mL of methanol, and the resulting extract was passed through 50 g of activated charcoal and was then concentrated to approximately 10 mL (forming viscous precipitates) by evaporation. Viscous precipitates were first washed with 10 mL chloroform and were then re-resolved with 10 mL of methanol to which 500 mL chloroform was added. After removal of unresolved materials by filtration, solvents were re-evaporated. Substances were then concentrated to approximately 20 mL and were applied onto a silica gel column (100 mL; Nacalai, Kyoto, Japan). Melanin-suppressing substances were eluted as 2 peaks when chloroform:methanol (85: 15) was used as the eluate. The latter peak fraction was concentrated and applied onto a C 18 -ODS column (4.6 × 50 mm, Cosmosil MS-II; Nacalai). The main peak was collected, and substances were recovered in ethyl acetate and reconcentrated by evaporation. The precipitates were then dissolved in 1 mL of ethanol to be hydrolyzed with 9 mL of 1% H 2 SO 4 -water at 100 ° C for 30 min. The hydrolyzate was recovered in ethyl acetate, evaporated, suspended in 20% acetonitrile-water, and applied again onto the C 18 -ODS column. The main peak was collected, and substances were again recovered in ethyl acetate and re-concentrated by evaporation.
Fr. 6 and 6 ′ (hydrolyzed) were purified by recycling HPLC onto an ODS column (15 × 150 mm i.d., SunFire Prep C18 OBD, Waters; solvent system, 20% acetonitrile/water) to obtain 11α-OH KA (2.0 mg).
Preparation of 11α-OH KA Methyl Ester
Synthesis of 11α-OH KA methyl ester was prepared as described previously [15] . Briefly, 11α-OH KA (5 mg, 1.6 × 10 
Cell Culture
Mouse B16F10 melanoma cells from the American Type Culture Collection (Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM, 5.5 m M D -glucose; WAKO), supplemented with 10% fetal bovine serum and antibiotics. Cells were incubated in a humidified atmosphere with 5% CO 2 at 37 ° C and were transferred every 2 days via trypsinization to new culture dishes.
Human Epidermal Equivalents (3D Human Skin Model)
Preparation of materials from human souse was undertaken through the application and approval of strict ethical principles of the provider Japan Tissue Engineering Co., Ltd., Aichi, Japan (also see http://www.jpte.co.jp/english/business/ethical_policy.html). The human epidermal equivalents, consisting of multilayered human keratinocytes and melanocytes (LabCyte Melano-Model, Tissue Engineering Co., Ltd., Aichi, Japan), were cultured at 37 ° C in the manufacturer-supplemented melanogenic medium (with stem cell factor and endothelin 1). Compounds were dissolved in PBS and applied to the surface of the epidermis tissue. The media and compounds were exchanged every 2 days. After 14 days, epidermal equivalents were subjected to melanin measurement and visualization.
Fontana-Masson Staining
Cell layers of 3D human skin models were fixed in 4% paraformaldehyde/PBS for 24 h and embedded in paraffin. Melanin on sections (3 μm thick) was visualized by Fontana-Masson staining.
Assay for Melanin Content
Melanin measurement was performed as described previously [14] . Briefly, the cells were washed twice with phosphate-buffered saline and were recovered in 2-mL collection tubes, followed by centrifugation at 8,000 rpm for 1.5 min. Each cell pellet was suspended in 300 μL of 1 M NaOH and were then lysed by incubation at 45 ° C for 2 h. Melanin was extracted with a 2: 1 chloroformmethanol mixture and was measured with a spectrophotometer (Model 680; Bio-Rad, Hercules, CA, USA) at 405 nm. The protein concentration of the cell pellets was determined using Bradford reagent (Bio-Rad) and was used for normalization of the melanin content.
Quantitative Real-Time PCR Quantitative real-time PCR analysis, including primer sets, has been described previously [14] . Briefly, total RNA was extracted using an EZ1 RNA Universal Tissue Kit (Qiagen, The Netherlands), and cDNA was synthesized using a ReverTra Ace qPCR RT Master Mix (Toyobo, Osaka, Japan). qPCR amplification was performed using EXPRESS SYBR GreenER (Thermo Fisher Scientific). Each of the mRNA expression levels were normalized against the GAPDH mRNA.
Reporter Assay
Procedures of recombinant DNA experiments were approved by the Committee in National Institutes of Biomedical Innovation, Health and Nutrition. The pGL3-mouse tyrosinase promoter and mouse MITF overexpression vectors have been described previously [14] . To prepare the 3× M-box-luciferase vector, 2 complementary nucleotides (5 ′ -CGC GAA AAG TCA GTC ATG TGC TTT TCA AAA GTC AGT CAT GTG C TT TTC AAA AGT CAG TCA TGT GCT TTT C and 5 ′ -GAT CGA AAA GCA CAT GAC TGA CTT TTG AAA AGC ACA TGA CTG ACT TTT GAA AAG CAC ATG ACT GAC TTT T) were annealed at room temperature. The DNA fragment was ligated into the Mlu I/ Bgl II site of the pTAL-luciferase vector (Takara, Kyoto, Japan).
To construct the mouse tyrosinase promoter with mutation, primers were used in which the M-box region TCA GTC ATG TG was converted to GCG GCC GCG TG using 5 ′ and 3 ′ 20-mer flanking regions. For E-box mutation, the E-box region CAT GTG was converted to GGA TCC. The pGL3-mouse tyrosinase promoter vector was amplified using these primers. To construct the double mutant, the M-box mutant vector was amplified using the E-box mutation primers.
Using Lipofectamine 2000 (Thermo Fisher Scientific, Carlsbad, CA, USA), B16F10 melanoma cells plated onto a 24-well plate were cotransfected with the pGL3-mouse tyrosinase promoter or pTAL 3× M-box (0.25 μg/well) with the internal reporter pRL-TK (0.05 μg), in the presence or absence of the Mitf expression vector (pTarget-mouse Mitf, 0.05 μg). After 24 h, the Fsk (20 μ M ) and 11α-OH KA (1-30 μ M ) were added, and cells were cultured further for 24 h. Reporter activity was monitored using the Dual Luciferase Reporter Assay Kit (Promega).
Results
Purification of Melanin-Synthesis Inhibitors from P. dispar
To identify plant extracts that contain unique melanogenesis suppressors, we collected the leaves of >100 ferns and assessed their ability to inhibit melanin synthesis in Fsk-stimulated B16F10 melanoma cells. Of all plants tested from the fern-library, the extract from P. dispar Kunze showed the strongest inhibitory effect on melanin synthesis.
To identify the active inhibiting components of the extract, we first soaked the leaves in methanol and passed the extract through an activated charcoal column. Then, we fractionated the eluent by silica gel chromatography ( Fig. 1 a) and separated the candidates into 2 fractions (fraction [Fr.] 4 and 6; Fig. 1 b) . LC-MS analyses suggested that Fr. 6 contained glycosylated compounds composed in Fr 4. Additionally, the main peak after LC separation (C 18 -ODS) appears to be composed of at least 2 compounds with a difference of 2 atomic mass units. Because Fr. 4 contained fewer substances than Fr. 6, we tried to separate the main peak in Fr. 6 into the 2 component compounds by recycling column chromatography (Fig. 1c) .
After 10 cycles, the 2 compounds were clearly separated, and a thin-layer chromatograph revealed that 1 compound showed strong absorption under UV irradiation (254 nm) (Fr. B) and the other did not (Fr. A) ( Fig. 1 d) . MS analyses ( Fig. 1 e) suggested that these compounds were glycosylated diterpenes. Based on HRESIMS and 1 H-NMR data, which had some impurities, Fr. A was deduced to be ent-11α-hydroxy-15-oxokaur-19-oic acid 3-glucoside (11α-OH 16,17-dihydro KA 3-glucoside) [16] , whereas Fr. B contained 11α-OH KA 3-glucoside, the enone form of the compound in Fr. A [16] . Only Fr. B was able to inhibit melanogenesis in B16F10 melanoma cells.
Fr. 6 was subjected to hydrolysis to deglycosylate the 11α-OH KA compound. Then, the deglycosylated kaurens were collected by C 18 -ODS column chromatography (Fr. 6′; Fig. 1 f) , and 11α-OH KA was separated using recycling column chromatography, and its structure was confirmed to be 11α-OH KA by NMR analyses (see Materials and Methods).
11α-OH KA Inhibits Melanin Synthesis in a Dose-Dependent Manner
To elucidate the mode of action of 11α-OH KA, B16F10 melanoma cells were treated with Fsk for 72 h along with 11α-OH KA ( Fig. 2 a) . Quantification of the melanin content in B16F10 cells showed that 11α-OH KA inhibited melanin synthesis in a dose-dependent manner ( Fig. 2 b) . A 3D human skin model suggested that, despite weak significance, 1 and 3 m M 11α-OH KA more efficiently inhibited melanin synthesis than 1% kojic acid (approximately 70 m M , often included in cosmetic items) ( Fig. 2 c, d ).
11α-OH KA Suppresses Tyrosinase Expression
Since Fsk rapidly induces MITF activity, which then promotes expression of melanogenic enzymes, including tyrosinase, we first examined the effects of 11α-OH KA on MITF expression in B16F10 melanoma cells. Quantitative PCR ( Fig. 3 a) and Western blot analyses ( Fig. 3 b) showed that 11α-OH KA had no effect on MITF expression despite unexplainable inhibition of Mitf mRNA levels when it is added without Fsk. In addition, activation (phosphorylation) levels of key molecules, such as CREB, ERK, and p38, at the early phase of the Fsk treatment were not changed by 11α-OH KA ( Fig. 3 c) . On the other hand, both tyrosinase mRNA and protein levels ( Fig. 3 d, e) were suppressed by 11α-OH KA, possibly independent of the Fsk treatment (mRNA levels in Fig. 3 d) . 
11α-OH KA Suppresses Tyrosinase Promoter Activity
To examine whether the reduction of tyrosinase mRNA levels was the result of suppression of promoter activities, we performed a reporter assay using the − 1.8 kb mouse tyrosinase promoter-luciferase vector ( Fig. 4 a) . The tyrosinase promoter activity was inhibited by 11α-OH KA in a dose-dependent manner. To rule out the possible contribution of MITF to this suppressed activity, 2 MITF-binding sites (M-and E-box) were disrupted and used in the reporter assay ( Fig. 4 b) . The suppressive effects of 11α-OH KA on the tyrosinase promoter were weakened with disruption of the MITF-binding site, particularly with the M-box, and the suppression of 11α-OH KA was completely eliminated with double-site disruption. Given our observations regarding MITF mRNA and protein levels ( Fig. 3 a, b) , overexpression of MITF created further confusion that the overexpressed MITF prevented 11α-OH KA-induced suppression of tyrosinase promoter activity ( Fig. 4 c) .
To verify the role of MITF and the effect of its expression level on 11α-OH KA-mediated suppression of tyrosinase promoter activity, we constructed a 3× M-boxluciferase vector ( Fig. 4 d) . Neither the basal (without Fsk) nor the stimulated (by Fsk or MITF overexpression) Mbox-derived promoter activities were affected by 11α-OH KA. These results suggest that 11α-OH KA-mediated suppression of tyrosinase promoter activity requires MITF. However, 11α-OH KA might not act through One possibility is that 11α-OH KA inhibits unknown factors that support MITF recruitment to the tyrosinase promoter.
Structure-Activity Relationship of ent-Kaurens on Melanin Synthesis Inhibition
Finally, we examined the structure-activity relationship of 11α-OH KA and its related compounds on the suppressive activities it has: only 11α-OH KA could sup- press melanogenesis ( Fig. 1 e, Fig. 5 a) , whereas the other related compounds examined were not, suggesting that the OH group at C-11α, carbonyl group at C-15, and double bond at C-16 are essential for suppression of melanogenic activity. The importance of 11α-OH KA was confirmed in 3D human skin models ( Fig. 5 b) . Both unstained images (surface and bottom) and melanin visualization by Fontana-Masson (vertical section) suggested that 11α-OH KA decreased the number of melanin-containing cells in the 3D human skin models, especially at the basement side.
During purification of 11α-OH KA, we noticed that glycosylation at the C-19 position might not be essential to suppress melanogenesis. To examine the importance of the C-19 position, we modified the COOH group to methyl ester ( Fig. 5 c) . The methylated compound more efficiently suppressed melanogenesis than did 11α-OH KA ( Fig. 5 d) , suggesting that 11α-OH KA methyl ester might be efficiently incorporated into cells, and the COOH group at C-19 was not essential for the melanogenenic suppressive activity of 11α-OH KA.
Finally, we reviewed cell toxicity of 11α-OH KA. In B16F10 melanoma cells, 11α-OH KA and its related compounds having the COOH group at their 19 position did not show cell toxic activity up to 30 μ M ( Fig. 6 a) . In contrast, 11α-OH KA methyl ester showed cell toxicity at 3 μ M . Moreover, rosthornin A that has hydroxymethyl at its 19 position showed high cell toxicity, suggesting that the COOH group at the 19 position reduced cell toxicity of these kaurens.
Discussion
Here, we have shown that 11α-OH KA from P. dispar Kunze leaf extract strongly inhibited melanogenesis in mouse B16F10 melanoma cells and 3D human skin model without obvious cellular toxicity.
Originally found in Pteris semipinnata, 11α-OH KA was shown to inhibit cell proliferation and induce apoptosis in several cell lines [17, 18] . When human lung cancer A549 cells are treated with 20-80 μg/mL (approximately 60-240 μ M ) of 11α-OH KA, the induction of the apoptotic factor p21 and activation of caspase-3 are observed [17] . In addition, 11α-OH KA induces mitochondrial mediated apoptosis in human nasopharyngeal carcinoma CNE-2Z cells, which is accompanied by a decrease of Bcl-2 and NF-κB protein levels [18] . However, no other physiologically relevant activity of 11α-OH KA, including suppression of melanogenesis, had been reported prior to the present report, which is the first study on the effect of 11α-OH KA on melanogenesis in mouse and human.
MITF is a key regulator of melanogenic processes and is regulated by a variety of signaling systems at different levels, including gene expression and posttranslational modifications. MITF is phosphorylated by mitogen-activated protein kinase, ribosomal S6 kinase, p38, and GSK3β [19] [20] [21] [22] . Phosphorylated MITF can bind to DNA (M-box) more efficiently than its dephosphorylated form. Since 11α-OH KA showed no effect on the MITF expres- 5 a) for 24 h. Cell viability was measured by using cell counting kit 8. Each value at OD450 was normalized by that without compounds (control) ( n = 5, means and SD are indicated). b The same assay was performed with 11α-OH KA, its methyl ester, or rosthornin A (the 19 position is hydroxymethyl) ( n = 5, means and SD are indicated). * p < 0.05, * * p < 0.01 compared with that with the control ( − ). sion level or on its activity on the synthetic M-box-derived reporter, the target of 11α-OH KA might be effectors of MITF present on the tyrosinase promoter. For example, the transcriptional coactivators CBP and p300 are known to interact with the N-terminal transactivation domain of MITF [23, 24] and activate MITF-dependent transcription. Similarly, lymphoid enhancer-binding factor 1 binds to the tyrosinase promoter and promotes MITF-dependent tyrosinase gene expression [25, 26] .
In this study, 11α-OH KA from P. dispar Kunze strongly inhibited melanin production in mouse B16F10 melanoma cells and 3D human skin model. In contrast to the apoptotic activities of 11α-OH KA and its related kaurens, this melanogenic inhibitory effect highly depended on the specific chemical structure of this compound, suggesting that the melanogenic targets and signaling cascades modulated by 11α-OH KA might be different from those targeted in its cell death signaling activity. Notably, 11α-OH, 15-oxy, and 16-en moieties in the ent-kauren skeleton are essential for melanogenesis suppression, while the COOH group at the 19 position may contribute to escape from cellular targets that lead to cell death.
In addition to the antimelanogenic activity, we found that 11α-OH KA had anti-inflammatory activities, such as suppression of cytokine production, in human keratinocytes damaged by UV. To put 11α-OH KA's beneficial properties into practical use, we first registered "Pteris Dispar Leaf Extract" on the list of International Nomenclature of Cosmetic Ingredients, INCI, and the extract was subjected to human safety studies, including in vitro skin irritation tests using 3D human skin models, genotoxicity tests (Ames tests), in vivo primary skin irritation test (24-hour closed patch test), cumulative skin irritation and skin sensitization test (Repeated Insult Patch Test, RIPT), and in vitro 3T3 Neutral Red Uptake (NRU) phototoxicity test. Fortunately, the extract, up to 1% (w/w), has been found to have no toxic properties. Coupling with these safety studies, elucidation of the molecular mechanisms by which 11α-OH KA inhibits melanogenesis is also needed.
